Malignant Hyperthermia: Mith or reality. Are we prepared?

Authors

  • Llefer Vladimir Sanchez CEDIMAT
  • Ramón Pol Pichardo CEDIMAT, Santo Domingo.
  • Vicky Adames CEDIMAT, Santo Domingo.

Keywords:

Malignant hypertermia, dantrolene, cardiovascular anesthesia

Abstract

Malignant hyperthermia is a low-incidence, but potentially deadly, autosomal dominant drug-genetic disease characterized by an anaerobic hypermetabolic syndrome of the skeletal striatum muscle, which may trigger it's complete destruction, resulting in an increase in temperature, oxygen consumption, hyperkalemia, renal failure and arrhythmias. However, being a pathology with a high mortality (90%), and can be presented as a complication of an anesthetic process, our country have not reported cases of malignant hyperthermia, besides we do not have the specific treatment for this lethal complication.

Downloads

Published

2019-09-20

How to Cite

Sanchez, L. V., Pol Pichardo, R., & Adames, V. (2019). Malignant Hyperthermia: Mith or reality. Are we prepared?. Revista En Bomba, 2(1), 34–36. Retrieved from https://revistaenbombaalap.org/index.php/bomba/article/view/93

Issue

Vol. 2 No. 1 (2018)

Section

Presentación de casos

License

Los trabajos admitidos para publicación quedan en propiedad de los autores y su reproducción total o parcial está autorizada siempre y cuando se haga referencia a la fuente primaria y no se persigan fines comerciales (Licencia CC Reconocimiento-NoComercial 4.0). La Revista En bomba se reserva el derecho de reproducir (parcial o totalmente) sus publicaciones así reproducir sus contenidos en otros medios o soportes digitales o físicos.

Most read articles by the same author(s)